Sun Pharmaceuticals reported INR22.62B in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Aspen Pharmacare APN:SJ ZAR 3.13B 232M
Bharat Petroleum BPCL:IN INR 17.47B 20.85B
Cipla CIPLA:IN INR 8.01B 120.6M
Dr.Reddys Laboratories DRRD:IN INR 12.44B 1.3B
Jiangsu Hengrui Me. 600276:CH CNY 1.05B 171.68M
Reliance Infra RELI:IN INR 157.92B 21.36B
Sh Fosun Pharma 600196:CH CNY 907.03M 177.79M
UPL UPLL:IN INR 10.87B 2.73B